Mark D. Perrin

Biography

Mr. Perrin is an experienced senior executive and leader with demonstrated success in building businesses, commercializing products, business development, and raising capital. Before joining InVivo Therapeutics in January 2014, he served as President of Dennan Consulting, a biotech consulting firm. From 2005 to 2010, he served as President and Chief Executive Officer of ConjuChem Biotechnologies, a company developing long-acting conjugated peptide therapeutics. From 2002 to 2005, he was Executive Vice President and Chief Commercial Officer for Orphan Medical, a company focused on drug development for orphan diseases, principally in the central nervous system therapeutic areas. Prior to that, he was the Executive Vice President, Commercial Operations for COR Therapeutics from 1995 to 2001. Mr. Perrin earned his Bachelor of Science degree in economics from Fordham University and Master of Business Administration degree in marketing and international business from the Kellogg Graduate School of Management at Northwestern University.  

Research Interest

Biomaterials and biotechnology company, spinal cord injury research, treatments for spinal cord injury (SCI)